| Clinical applications of B-type natriuretic peptide (BNP) testing. | |
| | |
MedLine Citation:
|
PMID: 14522565 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Many claims have been made in recent years regarding the utility of plasma B-type natriuretic peptide (BNP) concentration measurements in the diagnosis, risk stratification and monitoring of patients with heart failure. This paper summarizes the current evidence and provides guidance for practising clinicians. Overall, plasma BNP testing appears to be of most value in the diagnostic arena, where it is likely to improve the performance of non-specialist physicians in diagnosing heart failure. In clinical practice, BNP testing is best used as a 'rule out' test for suspected cases of new heart failure in breathless patients presenting to either the outpatient or emergency care settings; it is not a replacement for echocardiography and full cardiological assessment, which will be required for patients with an elevated BNP concentration. Although work is ongoing in establishing the 'normal' values of BNP, heart failure appears to be highly unlikely below a plasma concentration of 100 pg/ml. However, as BNP levels rise with age and are affected by gender, comorbidity and drug therapy, the plasma BNP measurement should not be used in isolation from the clinical context. |
| | |
Authors:
|
M R Cowie; P Jourdain; A Maisel; U Dahlstrom; F Follath; R Isnard; A Luchner; T McDonagh; J Mair; M Nieminen; G Francis |
Related Documents
:
|
19183225 - Elevated ck-mb mass and plasma brain-type natriuretic peptide concentrations following ... 11176165 - Alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in pla... 2963545 - Circadian rhythm of plasma atrial natriuretic peptide, aldosterone, and blood pressure ... 6775955 - The effect of maximal exertion on the levels of plasma peptides in cyclists with differ... 21084385 - Kisspeptin and fertility. 11293005 - Polycystic ovary syndrome and hyperprolactinemia. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: European heart journal Volume: 24 ISSN: 0195-668X ISO Abbreviation: Eur. Heart J. Publication Date: 2003 Oct |
Date Detail:
|
Created Date: 2003-10-02 Completed Date: 2003-12-10 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8006263 Medline TA: Eur Heart J Country: England |
Other Details:
|
Languages: eng Pagination: 1710-8 Citation Subset: IM |
Affiliation:
|
National Heart & Lung Institute, Imperial College, London, UK. m.cowie@imperial.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Ambulatory Care Emergency Service, Hospital Fluorescent Antibody Technique / methods, standards Heart Failure / diagnosis* Humans Laboratory Techniques and Procedures / standards Luminescent Measurements Natriuretic Peptide, Brain / blood* Point-of-Care Systems / standards Prognosis Sensitivity and Specificity Ventricular Dysfunction, Left / diagnosis |
| Chemical | |
Reg. No./Substance:
|
114471-18-0/Natriuretic Peptide, Brain |
| Comments/Corrections | |
Comment In:
|
Eur Heart J. 2004 Apr;25(7):621
[PMID:
15120064
]
Eur Heart J. 2004 Nov;25(21):1967 [PMID: 15522477 ] Eur Heart J. 2004 Jun;25(12):1085; author reply 1085-6 [PMID: 15191781 ] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The public health implications of world trade negotiations on the general agreement on trade in serv...
Next Document: Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to th...